Hemodynamic stabilization of the patient in septic shock by elimination of inflammatory mediators with hemoadsorptio

Not Applicable

• Conditions: R57.2; Septic shock

• Registration Number: DRKS00032509
• Lead Sponsor: Gemeinschaftsklinikum Mittelrhein (GKM), Standort Ev. Stift, Klinik für Intensivmedizin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-12-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Diagnosis of septic shock
Vasopressor requirement (noradrenaline > 0.3 µg/kg/min), if necessary plus vasopressin
Lactate serum concentration ( > 2 mmol/l)
Procalcitonin (PCT) > 3 µg/l
CytoScore after 6 hours > 6 points

Exclusion Criteria

Contraindications for the use of the respective procedures (according to approval)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hemodynamic stabilization within 72 hours after starting CytoSorb

Secondary Outcome Measures

Name	Time	Method
o secondary endpoint